GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Britannia Life Sciences Inc (XCNQ:BLAB) » Definitions » Other Net Income (Loss)

Britannia Life Sciences (XCNQ:BLAB) Other Net Income (Loss) : C$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Britannia Life Sciences Other Net Income (Loss)?

Britannia Life Sciences's Other Net Income (Loss) for the three months ended in Dec. 2023 was C$0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.00 Mil.

Britannia Life Sciences's quarterly Other Net Income (Loss) increased from Jun. 2023 (C$-0.00 Mil) to Sep. 2023 (C$0.00 Mil) and increased from Sep. 2023 (C$0.00 Mil) to Dec. 2023 (C$0.00 Mil).

Britannia Life Sciences's annual Other Net Income (Loss) increased from Mar. 2021 (C$-0.00 Mil) to Mar. 2022 (C$0.00 Mil) but then declined from Mar. 2022 (C$0.00 Mil) to Mar. 2023 (C$-0.00 Mil).


Britannia Life Sciences Other Net Income (Loss) Historical Data

The historical data trend for Britannia Life Sciences's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Britannia Life Sciences Other Net Income (Loss) Chart

Britannia Life Sciences Annual Data
Trend Mar21 Mar22 Mar23
Other Net Income (Loss)
- - -

Britannia Life Sciences Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Britannia Life Sciences Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Britannia Life Sciences Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Britannia Life Sciences's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Britannia Life Sciences (XCNQ:BLAB) Business Description

Traded in Other Exchanges
Address
120 Adelaide Street West, Suite 2400, Toronto, ON, CAN, M5H 1T1
Britannia Life Sciences Inc is a diversified product development, quality assurance, and safety & regulatory compliance company supporting clients in the CPG, cosmetics, household goods, and nutraceutical industries in the United Kingdom.

Britannia Life Sciences (XCNQ:BLAB) Headlines

No Headlines